Real-time PCR (qPCR) & Digital PCR (dPCR) Market

Real-time PCR (qPCR) & Digital PCR (dPCR) Market: Overview 

The global real-time PCR (qPCR) & digital PCR (dPCR) market is expected to rise at a significant pace during the forecast period, thanks to the rapid technological advancements. 

Digital PCR is defines as a next-generation testing method that helps in precise quantification of nucleic acids. Quantification of nuclei acids widely used in cancer treatment, the superior sensitivity and accuracy of the digital PCR-based approach is a prominent factor expected to boost the digital PCR market in the forecast period. Whereas Real time PCR is the advanced version of digital PCR (dPCR) with integration of advanced technology such as IoT and automation. 

An upcoming report on the real-time PCR (qPCR) & digital PCR (dPCR) market by Transparency Market Research is expected to offer an in depth analysis on industry. The report is anticipated to cover all segments in the market. Along with this, the report is anticipated to consist of vital data that will help indicating growth and latest trend in real-time PCR (qPCR) & digital PCR (dPCR market during the forecast period. 

Real-time PCR (qPCR) & Digital PCR (dPCR) Market: Notable Developments 

Some of the recent development in the real-time PCR (qPCR) & digital PCR (dPCR are- 

 For instance, in January 2019, QIAGEN N.V., a prominent player in the digital PCR market has announced its plans for the development of next-generation dPCR systems. This is expected offer several new opportunities to the market growth in the coming few years. 

Priviously, in 2018, AOAC INTERNATIONAL, a key player in the market is developing certified Bio-Rad Laboratories iQ-Check (Real-Time PCR Kit) to analyze for salmonella species. 

Some of the prominent players operating in the qPCR and dPCR market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Qiagen N.V., Abbott Laboratories, Inc., bioMerieux S.A., Fluidigm Corporation.; and F. Hoffman La Roche. These players are adopting several strategies such as mergers and acquisitions, business expansion and collaboration to stay ahead in the real-time PCR and digital PCR market. 

Real-time PCR (qPCR) & Digital PCR (dPCR) Market: Key Trends 

The global Real-time PCR (qPCR) & Digital PCR (dPCR) Market is likely to rise at a significant pace in the coming few years. This is mainly due to the increasing prevalence of the cancer and chronic disorder. Along with this, rising demand from for the devices from the genetic variation analysis, genotyping and gene expression analysis are some other factor expected to drive the global Real-time PCR (qPCR) & Digital PCR (dPCR) Market. Further, increasing focus towards the development of Point of Care (PoC) platforms is another factor projected to drive market growth. 

According to the World Health Organization (WHO), cancer accounted for 9.6 million deaths in 2018 globally. This alarming rise in prevalence of cancer is pressuring towards the development of advance cancer detection and treatment techniques. This is expected to offer a significant push to the market growth. 

Real-time PCR (qPCR) & Digital PCR (dPCR) Market: Regional Outlook 

On the basis of region, Asia Pacific is likely to witness highest growth during the forecast period. This is mainly because of the increasing patient pool due to the high prevalence of chronic and infectious diseases. Along with this, increasing consumer awareness about the diagnosis of these diseases is anticipated to fuel the Real-time PCR (qPCR) & Digital PCR (dPCR) Market in the region.